HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bliss World Opening 57th Street Spa In December

This article was originally published in The Rose Sheet

Executive Summary

Bliss World is opening its second New York City spa as part of new owner LVMH's expansion plans for the fledgling company. Situated in Manhattan's East Side on 57th Street, the 4,000 sq. ft. spa is designed to cater to the "indigenous" female population and will specialize in "profuse pampering, immeasurable luxury and service," the company said.

You may also be interested in...



Bliss World Sales Expected To Double To $23 Mil. In 1999 Under LVMH

LVMH's recently acquired U.S. spa company Bliss World is expected to double its sales to $23 mil. in 1999, according to Executive Director and Creative Director Marcia Kilgore, who founded the company in July 1996. Moet Hennessey Louis Vuitton acquired a 70% stake in the New York City-based spa and skin care firm, which also includes the Bliss Out home spa products catalog business, in March (1"The Rose Sheet" March 22, p. 11). Bliss sales in 1998 were $11 mil.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel